Merck & Co., Inc.
- SEC CIK
- 0000310158
- Latest filing
- Aug 7, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 12, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 13
- 0 vs. Q2 2025
- Portfolio value
- $228.0M
- +$12.4M (+5.8%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PSNLPersonalis, Inc. | COM | 14,044,943 | $91.6M | 40.2% | 00.0% | Unchanged | History |
| MRNAModerna, Inc. | Stock | 2,308,190 | $59.6M | 26.1% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 772,165 | $43.7M | 19.2% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 3,545,719 | $10.5M | 4.6% | 00.0% | Unchanged | History |
| Entrada Therapeutics Inc29384C908 | CALL | 1,739,768 | $10.1M | 4.4% | 00.0% | Unchanged | – |
| EVAXEvaxion A/S | COM | 1,214,126 | $4.57M | 2.0% | 00.0% | Unchanged | History |
| STROSutro Biopharma, Inc. | COM | 2,723,509 | $2.37M | 1.0% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 93,414 | $2.02M | 0.9% | 00.0% | Unchanged | History |
| LVTXLAVA Therapeutics NV | SHS | 1,149,345 | $1.79M | 0.8% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 1,483,758 | $1.25M | 0.5% | 00.0% | Unchanged | History |
| CARMCarisma Therapeutics Inc. | COM | 1,473,240 | $403.7K | 0.2% | 00.0% | Unchanged | History |
| NEUPNeuphoria Therapeutics Inc. | COM | 10,027 | $118.2K | 0.1% | 00.0% | Unchanged | History |
| HURATuHURA Biosciences, Inc. | COM | 13,950 | $34.6K | <0.1% | 00.0% | Unchanged | History |